InsidersTradesSigma
Follow the Supriya Lifescience Limited share price and the full management transaction log of the company, a publicly traded company based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Supriya Lifescience Limited has recorded 8 public disclosures. Market capitalisation: €69.8bn. The latest transaction was filed on 27 February 2024 (Purchase). Among the most active insiders: Satish Waman Wagh. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
Supriya Lifescience Limited is a company engaged in the manufacturing of pharmaceutical products. It operates in the healthcare and pharmaceutical sector, listed on the Bombay Stock Exchange.